Preparation and Biological Evaluation of <sup>64</sup>Cu-CB-TE2A-sst<sub>2</sub>-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors - Concepedia

Concepedia

Publication | Open Access

Preparation and Biological Evaluation of <sup>64</sup>Cu-CB-TE2A-sst<sub>2</sub>-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors

DOI Full Paper Access

74

Citations

26

References

2008

Year

Thaddeus J. Wadas, Martin Eiblmaier, Alexander Zheleznyak, Christopher D. Sherman, Riccardo Ferdani, Kexian Liang, Samuel Achilefu, Carolyn J. Anderson

Journal of Nuclear Medicine

Abstract

The PET radiopharmaceutical 64Cu-CB-TE2A-sst2-ANT is an attractive agent, worthy of future study as a PET radiopharmaceutical for the imaging of somatostatin receptor-positive tumors.

References

	Year	Citations
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser, European Journal of Nuclear Medicine and Molecular Imaging Human Somatostatin ReceptorAffinity ProfilesSomatostatin RadiotracersMedicinePathology	2000	1.1K
Efficient production of high specific activity 64Cu using a biomedical cyclotron Deborah W. McCarthy, R. E. Shefer, R. E. Klinkowstein, Nuclear Medicine and Biology EngineeringBiochemistryBiomedical CyclotronNatural SciencesBiotechnology	1997	524
Radiolabeled somatostatin receptor antagonists are preferable to agonists for<i>in vivo</i>peptide receptor targeting of tumors Mihaela Ginj, Hanwen Zhang, Beatrice Waser, Proceedings of the National Academy of Sciences EngineeringImmunologyPeptide SciencePharmacotherapyPeptide Therapeutics	2006	488
Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes C. Andrew Boswell, Xiankai Sun, Weijun Niu, Journal of Medicinal Chemistry	2004	476
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. Carolyn J. Anderson, Farrokh Dehdashti, Paul Cutler, PubMed	2001	275
Cross-bridged cyclam. Protonation and lithium cation (Li+) complexation in a diamond-lattice cleft Gary R. Weisman, Mark E. Rogers, Edward H. Wong, Journal of the American Chemical Society Materials ScienceInorganic ChemistryChemical EngineeringDiamond-lattice CleftEngineering	1990	164
99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. Clemens Decristoforo, Laura Meléndez‐Alafort, Jane Sosabowski, PubMed	2000	162
The in vivo behavior of copper-64-labeled azamacrocyclic complexes Teresa M. Jones-Wilson, Kim A. Deal, Carolyn J. Anderson, Nuclear Medicine and Biology Inorganic ChemistryCoordination ComplexMolecular ComplexChemistryVivo Behavior	1998	161
Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator Jennifer Sprague, Yijie Peng, Xiankai Sun, Clinical Cancer Research	2004	158
Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. Carolyn J. Anderson, Lynne A. Jones, Laura A. Bass, PubMed	1998	134

Page 1